You are here

vaccines

Clinical trial set to test efficacy of mixing Sputnik V and COVID-19 Vaccine AstraZeneca

Clinical trial set to test efficacy of mixing Sputnik V and COVID-19 Vaccine AstraZeneca

Biopharma Reporter

clinical trials

Flag link:

Pharma Sanofi CEO: mRNA is likely the 'go-to' vaccine tech for a pandemic, but the 'bar is high' in other diseases

Pharma Sanofi CEO: mRNA is likely the 'go-to' vaccine tech for a pandemic, but the 'bar is high' in other diseases

Fierce Pharma

Flag link:

Can COVID Vaccine Latecomer Ocugen Beat Pfizer and Moderna?

Can COVID Vaccine Latecomer Ocugen Beat Pfizer and Moderna?

Motley Fool

Flag link:

Novavax starts rolling reviews for COVID-19 vaccine

Novavax starts rolling reviews for COVID-19 vaccine

Biopharma Reporter

Flag link:

Pfizer to nearly halve COVID-19 vaccine production timeline, sterile injectables VP says

Pfizer to nearly halve COVID-19 vaccine production timeline, sterile injectables VP says

Fierce Pharma

drug manufacturing

Flag link:

4 in 5 Americans ready for COVID-19 shot, but vaccine messages remain key, analysis finds

4 in 5 Americans ready for COVID-19 shot, but vaccine messages remain key, analysis finds

Fierce Pharma

Flag link:

Pentagon to deploy troops to help with COVID-19 vaccine administration

Pentagon to deploy troops to help with COVID-19 vaccine administration

Beckers Hospital Review

Flag link:

South Africa halts AstraZeneca vaccine rollout over new variant

South Africa halts AstraZeneca vaccine rollout over new variant

BBC News

clinical trials

B.1.351 variant

Flag link:

Moderna sets sights on $200M vaccine factory in Seoul: report

Moderna sets sights on $200M vaccine factory in Seoul: report

Fierce Pharma

Moderna Therapeutics

drug manufacturing

Flag link:

Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big

Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big

Motley Fool

Moderna Therapeutics

Flag link:

Woodcock: FDA plans guidance to address new COVID-19 variants

Woodcock: FDA plans guidance to address new COVID-19 variants

RAPS.org

drug developments

Flag link:

BioNTech Gets Help From Merck KGaA in Move to Speed Covid Shots

BioNTech Gets Help From Merck KGaA in Move to Speed Covid Shots

Bloomberg

Flag link:

Novavax Initiates Rolling Review for Vaccine & Other COVID News

Novavax Initiates Rolling Review for Vaccine & Other COVID News

BioSpace

Flag link:

FDA arranges Feb. 26 AdComm to discuss J&J COVID-19 vaccine EUA

FDA arranges Feb. 26 AdComm to discuss J&J COVID-19 vaccine EUA

Fierce Biotech

advisory panels

Emergency Use Authorization

Flag link:

Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production

Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production

Xtalks

drug manufacturing

Flag link:

J&J asks FDA for emergency clearance of coronavirus vaccine

J&J asks FDA for emergency clearance of coronavirus vaccine

BioPharma Dive

Emergency Use Authorization

Flag link:

Could combining Pfizer's and AZ's COVID-19 vaccines fill supply gaps? U.K. researchers aim to find out

Could combining Pfizer's and AZ's COVID-19 vaccines fill supply gaps? U.K. researchers aim to find out

Fierce Pharma

clinical trials

Flag link:

Vaxart Disappoints With Coronavirus Vaccine Trial Update

Vaxart Disappoints With Coronavirus Vaccine Trial Update

Motley Fool

clinical trials

Flag link:

With a seductive number, AstraZeneca study fueled hopes that eclipsed its data

With a seductive number, AstraZeneca study fueled hopes that eclipsed its data

Stat

Flag link:

Novavax and Johnson & Johnson Seek Regulatory Approval for COVID-19 Vaccines After Posting Promising Efficacy Data

Novavax and Johnson & Johnson Seek Regulatory Approval for COVID-19 Vaccines After Posting Promising Efficacy Data

Xtalks

Flag link:

Pages